Nature cancer · 2025
The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shah Richa, Hanna Nader Mounir, Loo Ching Ee, David Michael, Mafra Allini, Fink Hanna, McFerran Ethna, Garcia Montse, Ghodssighassemabadi Robabeh, Acharya Suryakanta, Niyibaga Jean, Langselius Oliver, Frick Clara, Lasebikan Nwamaka, Vignat Jerome, Steinberg Julia, Hughes Suzanne, Kircher Colleen Elizabeth, Goldie Catherine Lindsay, Egger Sam, Sullivan Richard, Ginsburg Ophira, Bray Freddie, Caruana Michael, Hui Harriet, Ilbawi André Michel, Canfell Karen, Soerjomataram Isabelle
Аннотация
The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on cancer services, including diagnosis, diagnostic procedures, screening, treatment and supportive and palliative care. Based on data from 245 articles in 46 countries, we observed declines in the number of cancer screening participation (39.0%), diagnoses (23.0%), diagnostic procedures (24.0%) and treatment (28.0%), ranging from a 15.0% decline for radiotherapy to a 35.0% decline for systemic treatment during the pandemic compared to during the prepandemic period. Medium-human development index (HDI) category countries experienced greater reductions than high- and very-high-HDI countries. Missing data from low-HDI countries emphasize the need for increased investments in cancer surveillance and research in these settings. PROSPERO registration: CRD42022301816.